Skip to content
Saturday, October 04, 2025

Boise Chronicle

Boise Breaking News & Events

The location could not be found.
  • News
  • Sports
  • Weather
  • Life
  • Money
  • Tech
  • Travel

Author: Elizabeth Weise and Karen Weintraub, USA TODAY

Nation

Scientists achieve major advance in fusion energy that could provide clean, carbon-free power

December 13, 2022Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on Scientists achieve major advance in fusion energy that could provide clean, carbon-free power

The fusion breakthrough could mean carbon-free power, but not soon. And it’s not going to be like ‘Mr. Fusion’ from ‘Back to the Future II.’

Nation

Omicron is spreading ‘every place at once,’ experts say. What it could mean for holiday plans.

December 14, 2021December 15, 2021Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on Omicron is spreading ‘every place at once,’ experts say. What it could mean for holiday plans.

A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S.

News

FDA panel recommends Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk

September 17, 2021September 17, 2021Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on FDA panel recommends Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk

There isn’t yet sufficient evidence to support boosters for people under 65, the FDA Vaccines and Related Biological Products Advisory Committee said.

News

Moderna says its COVID-19 vaccine found to be 100% effective in children 12 to 17 two weeks after second dose

May 25, 2021May 25, 2021Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on Moderna says its COVID-19 vaccine found to be 100% effective in children 12 to 17 two weeks after second dose

The Moderna vaccine was 93% effective against COVID-19 in teenagers aged 12 to 17 after the first dose and 100% two weeks after the second dose.

News

The coronavirus variant that first appeared in India is in the US. Here’s what to know.

May 17, 2021Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on The coronavirus variant that first appeared in India is in the US. Here’s what to know.

Experts say it likely will not cause great harm in the U.S. because of high vaccination rates and our health care system, but they are watching it.

News

Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume

April 23, 2021April 23, 2021Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume

The pause on the one-dose J&J COVID vaccine will be lifted and distribution will resume in the U.S., FDA officials said Friday night.

News

Amid a chaotic COVID-19 vaccine rollout, states find ways to connect shots with arms

March 1, 2021Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on Amid a chaotic COVID-19 vaccine rollout, states find ways to connect shots with arms

Under a decentralized national health care system and a chaotic COVID-19 vaccine rollout, states find their own ways to reach and vaccinate residents.

News

CDC-convened committee votes to add nursing home residents to first phase of COVID-19 vaccine access

December 2, 2020Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on CDC-convened committee votes to add nursing home residents to first phase of COVID-19 vaccine access

Everyone in Phase 1a should be able to get the first of the two-shot COVID-19 vaccine series within three weeks of one being authorized by the FDA.

News

Johnson & Johnson pauses COVID-19 vaccine trial due to unexplained illness — the second US trial now on hold

October 12, 2020October 12, 2020Elizabeth Weise and Karen Weintraub, USA TODAYComments Off on Johnson & Johnson pauses COVID-19 vaccine trial due to unexplained illness — the second US trial now on hold

The Phase 3 clinical trial was temporarily halted Monday because of an unexplained illness in one of the participants, Johnson & Johnson said.

Headlines

Sanae Takaichi Is Likely to Be Japan’s Next Leader. Who Is She?

October 4, 2025October 4, 2025Javier C. Hernández and Hisako Ueno

For the New Archbishop of Canterbury, Nursing Roots Could Bring a Pastoral Sensibility

October 4, 2025October 4, 2025MARK LANDLER

For Netanyahu, Trump’s Nod to Peace Puts Him in a Tough Spot

October 4, 2025DAVID M. HALBFINGER

Best Intentions

October 4, 2025Melissa Kirsch

What You Want to See Emerge from the Canada Post Walkout

October 4, 2025Ian Austen and Vjosa Isai

Canada Post Strike Poses Challenges for Remote Communities

October 4, 2025Matina Stevis-Gridneff and Pat Kane

Israel and Hamas Say They’ll Work With Trump’s Gaza Plan, but Gaps Remain

October 4, 2025October 4, 2025DAVID M. HALBFINGER

Japan Is Set for Its First Female Prime Minister

October 4, 2025October 4, 2025Javier C. Hernández, River Akira Davis and Hisako Ueno

Japan Set for First Female Prime Minister

October 4, 2025Javier C. Hernández, River Akira Davis and Hisako Ueno

Cautious Optimism on Gaza Peace Plan, but No Guarantees. Here’s What to Know.

October 4, 2025October 4, 2025John Yoon
  • News
  • Sports
  • Weather
  • Life
  • Money
  • Tech
  • Travel
  • Tampa Herald
  • Reno Chronicle
  • New Orleans Courier
  • Flint Chronicle
  • St. Louis Herald
  • Boise Chronicle
  • Anchorage Herald
  • Madison Chronicle
  • Chula Vista Chronicle
  • Newark Chronicle
  • Stockton Chronicle
  • Pittsburg Herald
  • Toledo Herald
2020 editorial | Editorial by MysteryThemes.